Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NVAX

Novavax Inc

May 08 • 04:00PM ET

10.11

+0.88 9.53 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ARCT INO MRNA BNTX VIR

| Held by: XBI VTI IWM VB VBK VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.60	Insider Own	4.92%	Shs Outstand	164.42M	Perf Week	25.75%
Market Cap	1.66B	Forward P/E	-	EPS next Y	-0.20	Insider Trans	0.00%	Shs Float	156.34M	Perf Month	18.38%
Enterprise Value	1.17B	PEG	-	EPS next Q	-0.37	Inst Own	67.78%	Short Float	29.64%	Perf Quarter	22.55%
Income	-87.83M	P/S	2.79	EPS this Y	-118.60%	Inst Trans	2.66%	Short Ratio	10.66	Perf Half Y	31.47%
Sales	596.34M	P/B	-	EPS next Y	58.32%	ROA	-7.52%	Short Interest	46.34M	Perf YTD	50.45%
Book/sh	-0.88	P/C	2.10	EPS next 5Y	-	ROE	-	52W High	11.97 -15.54%	Perf Year	51.80%
Cash/sh	4.81	P/FCF	-	EPS past 3/5Y	- -	ROIC	-59.27%	52W Low	5.80 74.31%	Perf 3Y	35.70%
Dividend Est.	-	EV/EBITDA	19.60	Sales past 3/5Y	-17.24% 18.76%	Gross Margin	84.92%	Volatility	10.13% 5.41%	Perf 5Y	-94.26%
Dividend TTM	-	EV/Sales	1.96	EPS Y/Y TTM	-117.68%	Oper. Margin	6.24%	ATR (14)	0.57	Perf 10Y	-89.03%
Dividend Ex-Date	Dec 13, 2007	Quick Ratio	2.45	Sales Y/Y TTM	-52.48%	Profit Margin	-14.73%	RSI (14)	70.42	Recom	2.44
Dividend Gr. 3/5Y	- -	Current Ratio	2.48	EPS Q/Q	-101.99%	SMA20	19.36%	Beta	2.36	Target Price	14.11
Payout	0.00%	Debt/Eq	-	Sales Q/Q	-79.07%	SMA50	12.24%	Rel Volume	3.06	Prev Close	9.23
Employees	749	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	22.71%	Avg Volume	4.34M	Price	10.11
IPO	Dec 05, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	75.19% 74.82%	Trades		Volume	13,306,788	Change	9.53%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-24-25	Resumed	Cantor Fitzgerald	Overweight	$18
Aug-28-25	Resumed	H.C. Wainwright	Buy	$10
Aug-20-25	Downgrade	BofA Securities	Neutral → Underperform	$7
Jun-17-25	Initiated	Citigroup	Sell	$6
Feb-28-25	Initiated	BTIG Research	Buy	$19
Jul-30-24	Downgrade	JP Morgan	Neutral → Underweight	$8
May-10-24	Upgrade	JP Morgan	Underweight → Neutral
May-10-24	Upgrade	BofA Securities	Underperform → Neutral	$4 → $12
Aug-09-23	Upgrade	B. Riley Securities	Neutral → Buy	$15
Apr-20-23	Downgrade	TD Cowen	Outperform → Market Perform	$55 → $10
Mar-01-23	Downgrade	B. Riley Securities	Buy → Neutral	$29 → $10
Jan-09-23	Reiterated	B. Riley Securities	Buy	$74 → $37
Dec-30-22	Reiterated	H.C. Wainwright	Buy	$207 → $110
Dec-02-22	Initiated	Jefferies	Hold
Sep-22-22	Downgrade	JP Morgan	Neutral → Underweight	$132 → $27
May-20-22	Initiated	BofA Securities	Underperform	$35
Feb-23-22	Reiterated	B. Riley Securities	Buy	$315 → $265
Feb-22-22	Resumed	Jefferies	Buy	$198
Jan-21-22	Initiated	Cowen	Outperform	$150
May-12-21	Downgrade	JP Morgan	Overweight → Neutral	$285 → $161

Show Previous Ratings

May-07-26 04:00PM	Novavax to Participate in BofA Securities 2026 Health Care Conference (PR Newswire) +9.53%
May-06-26 04:50PM	Novavax, Inc. Q1 2026 Earnings Call Summary (Moby) +15.56%
08:08AM	Novavax: Q1 Earnings Snapshot (Associated Press)
08:00AM	Novavax Reports First Quarter 2026 Financial Results and Operational Highlights (PR Newswire)
Apr-29-26 04:00PM	Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 (PR Newswire)
07:49AM	Loading…
Apr-08-26 07:49AM	Activist investor revives campaign to overhaul Novavax board (BioPharma Dive) +5.51%
Mar-30-26 08:00AM	Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development (PR Newswire)
Mar-03-26 09:00AM	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? (Zacks) -6.13%
Feb-27-26 02:20PM	What's Going On With Novavax Stock On Friday? (Benzinga) -9.38%
12:40PM	Why Novavax (NVAX) Shares Are Falling Today (StockStory)
08:26AM	Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates (Zacks)
06:43AM	Company News for Feb 27, 2026 (Zacks)
01:54AM	Novavax Stock Hits Over 1-Year High: Is Sanofis Flu-COVID Shot The Post-Pandemic Growth Driver? (New feeds test provider finance)
12:31AM	NVAX Q4 Deep Dive: Partnership-Led Strategy and Pipeline Transition Shape Outlook (StockStory)
12:07AM	Novavax Q4 Earnings Call Highlights (MarketBeat)
04:30PM	Loading…
Feb-26-26 04:30PM	Novavax to Participate in Upcoming Investor Conferences (PR Newswire) +17.42%
04:11PM	Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
03:55PM	Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising (Yahoo Finance Video)
02:19PM	COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb (Benzinga)
12:15PM	Novavax (NVAX) Beats Q4 Earnings and Revenue Estimates (Zacks)
12:10PM	Why Is Novavax (NVAX) Stock Soaring Today (StockStory)
08:46AM	Novavax shares subdued despite earnings, revenue beat (Investing.com)
08:17AM	Novavax: Q4 Earnings Snapshot (Associated Press Finance)
08:06AM	Novavax (NASDAQ:NVAX) Surprises With Strong Q4 CY2025 (StockStory)
08:00AM	Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights (PR Newswire)
Feb-25-26 06:09AM	Novavax (NVAX) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-23-26 12:00PM	Novavax (NVAX) Upgraded to Buy: Here's What You Should Know (Zacks)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:07AM	What's in Store for These 5 Medical Companies This Earnings Season? (Zacks)
Feb-19-26 08:00AM	Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (PR Newswire) +6.16%
09:00AM	Loading…
Feb-17-26 09:00AM	Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? (Zacks)
Feb-11-26 05:45PM	Novavax (NVAX) Rises As Market Takes a Dip: Key Facts (Zacks) -6.13%
Feb-06-26 09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-03-26 05:45PM	Why Novavax (NVAX) Dipped More Than Broader Market Today (Zacks)
Jan-31-26 07:58AM	BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets (Insider Monkey)
Jan-29-26 08:50AM	This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy? (Motley Fool)
Jan-28-26 05:45PM	Here's Why Novavax (NVAX) Fell More Than Broader Market (Zacks) -6.01%
03:00AM	Has Novavax cracked the code for survival in the vaccine arena? (Pharma Voice)
Jan-26-26 12:16PM	Novavax Stock Is Surging Monday: What's Driving The Action? (Benzinga) +5.02%
09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-22-26 05:45PM	Novavax (NVAX) Stock Dips While Market Gains: Key Facts (Zacks) -5.95%
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-21-26 03:40PM	Why Are Novavax (NVAX) Shares Soaring Today (StockStory) +20.73%
10:06AM	Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer (Zacks)
07:25AM	Pfizer and Novavax ink $530m vaccine delivery licensing deal (Pharmaceutical Technology)
05:38AM	Moderna cancer vaccine holds up; IO Biotech considers a sale (BioPharma Dive)
Jan-20-26 12:53PM	Novavax Pops on Pfizer Licensing Deal (GuruFocus.com)
10:42AM	Novavax Shares Rise After Licensing Deal With Pfizer (Benzinga)
09:59AM	Novavax Licenses Rights to Key Vaccine Component to Pfizer (The Wall Street Journal)
07:15AM	Novavax Announces Entering into a License Agreement with Pfizer (PR Newswire)
Jan-15-26 06:19PM	JPM26: Matrix-M Technology is central to Novavaxs strategy (Pharmaceutical Technology) -5.01%
Jan-14-26 05:45PM	Why Novavax (NVAX) Dipped More Than Broader Market Today (Zacks) -5.54%
08:19AM	Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last? (Zacks)
Jan-13-26 03:23PM	Why Is Novavax Stock Soaring? (Benzinga) +11.87%
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-12-26 11:27AM	Why Moderna Stock Is Dropping After Good News (Barrons.com) +6.60%
Jan-07-26 08:00AM	Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-05-26 05:45PM	Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-04-26 10:39PM	Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks (StockStory)
Jan-02-26 11:01AM	Novavax (NVAX) Stock Trades Up, Here Is Why (StockStory) +6.10%
Jan-01-26 05:43PM	Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales (StockStory)
Dec-30-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-19-25 09:00AM	Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know (Zacks)
Dec-11-25 01:01PM	Why I Wouldn't Touch Novavax With a 10-Foot Pole (Motley Fool)
Dec-08-25 09:00AM	Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock (Zacks)
Dec-05-25 05:05PM	Novavax, Inc. (NVAX): A Bull Case Theory (Insider Monkey)
Dec-02-25 09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily) -5.11%
03:05PM	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks (Investopedia)
12:24PM	Nvidia's Synopsys investment, Disney stock pops on Zootopia 2 (Yahoo Finance Video)
12:09PM	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino (Yahoo Finance Video)
11:05AM	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals (Barrons.com)
10:27AM	Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals (The Wall Street Journal)
10:09AM	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths (Investor's Business Daily)
09:59AM	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals (Barrons.com)
09:36AM	Moderna Falls as FDA Vows to Impose New Vaccine Requirements (Bloomberg)
07:34AM	Shares of vaccine makers drop after FDA memo flags reports of child deaths (Investing.com)
Nov-25-25 09:00AM	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? (Zacks)
08:39AM	Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast (Insider Monkey)
Nov-21-25 07:45PM	Novavax, UniFirst, and More Stocks See Action From Activist Investors (Barrons.com)
Nov-12-25 08:00AM	Novavax to Participate in Jefferies London Healthcare Conference (PR Newswire)
Nov-11-25 09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-07-25 11:27AM	Novavax Q3 Earnings & Revenues Beat Estimates, '25 Sales View Raised (Zacks)
12:15AM	Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges (GuruFocus.com)
Nov-06-25 09:15AM	Novavax (NVAX) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
09:01AM	Novavax beats revenue estimates, raises full-year guidance (Investing.com)
08:19AM	Novavax: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights (PR Newswire)
Nov-05-25 08:25AM	Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
Nov-04-25 07:00AM	Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid, Triggering a $25 Million Milestone Payment (PR Newswire) -5.06%
Oct-30-25 08:00AM	Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 (PR Newswire)
Oct-29-25 11:57AM	Novavax (NVAX) Gains Momentum with Sanofi Deal and Analyst Endorsement (Insider Monkey)
Oct-28-25 05:45PM	Novavax (NVAX) Stock Sinks As Market Gains: Here's Why (Zacks)
Oct-24-25 06:16PM	Novavax, Core Scientific, and More Stocks See Action From Activist Investors (Barrons.com)
09:34AM	Coinbase, eBay upgraded: Wall Street's top analyst calls (The Fly)
07:09AM	Sanofi says soft start to fall immunizations slowed vaccine sales (BioPharma Dive)
Oct-22-25 05:45PM	Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
07:00AM	Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy (PR Newswire)
Oct-21-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Oct-16-25 05:45PM	Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ruxandra Draghia Akli	Former Officer	May 07 '26	Proposed Sale	9.87	30,000	296,083		May 07 05:03 PM
Newton Charles W.	Director	Apr 25 '26	Option Exercise	0.00	9,520	0	9,520	Apr 28 05:00 PM
Shiver John W.	Director	Mar 10 '26	Option Exercise	0.00	7,947	0	7,947	Mar 12 05:00 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 07 '26	Option Exercise	0.00	12,223	0	136,503	Mar 09 06:13 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 03 '26	Option Exercise	0.00	43,167	0	145,130	Mar 05 06:04 AM
Jacobs John C	President and CEO	Mar 03 '26	Option Exercise	0.00	150,167	0	264,130	Mar 05 06:03 AM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 03 '26	Option Exercise	0.00	56,334	0	157,071	Mar 05 06:02 AM
Casey Mark J	EVP, Chief Legal Officer	Mar 03 '26	Option Exercise	0.00	37,500	0	101,445	Mar 05 06:01 AM
Draghia-Akli Ruxandra	EVP, Research & Development	Mar 03 '26	Option Exercise	0.00	26,667	0	34,876	Mar 05 06:00 AM
Jacobs John C	President and CEO	Mar 01 '26	Option Exercise	0.00	83,333	0	264,130	Mar 03 09:37 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 01 '26	Option Exercise	0.00	58,666	0	130,299	Mar 03 09:35 PM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 01 '26	Option Exercise	0.00	59,600	0	111,706	Mar 03 09:34 PM
Casey Mark J	EVP, Chief Legal Officer	Mar 01 '26	Option Exercise	0.00	4,000	0	65,159	Mar 03 09:33 PM
Jacobs John C	President and CEO	Jan 23 '26	Option Exercise	0.00	83,197	0	219,929	Jan 26 07:57 PM
Casey Mark J	EVP, Chief Legal Officer	Dec 11 '25	Option Exercise	0.00	41,899	0	73,972	Dec 15 04:01 PM
Draghia-Akli Ruxandra	Section 16	Nov 11 '25	Option Exercise	0.00	14,257	0	14,257	Nov 13 05:23 PM
MCGLYNN MARGARET G	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	25,588	Jun 16 04:10 PM
Alton Gregg H	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	28,805	Jun 16 04:09 PM
King Rachel K.	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	25,190	Jun 13 09:41 PM
Rodgers Richard J	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	24,690	Jun 13 09:40 PM
MOTT DAVID M	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	60,890	Jun 13 09:39 PM
DOUGLAS RICHARD	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	54,340	Jun 13 09:36 PM
YOUNG JAMES F	Former Director	May 19 '25	Proposed Sale	7.59	10,000	75,883		May 19 04:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVAX

Novavax Inc

Upgrade your Finviz experience